As Covid cases surge and the JN.1 variant is found in India, the Centre advises states to enhance RT-PCR testing and monitor influenza-like and acute respiratory illnesses. The Health Secretary emphasizes sustained efforts but urges constant vigilance. States are encouraged to implement public health measures for the upcoming festive season, reporting ILI and SARI cases promptly. The Ministry highlights the need for increased testing and genome sequencing to detect new variants. Kerala reports India's first JN.1 case, emphasizing the ongoing Covid challenges. The government aims to minimize transmission risks and sustain control during the festive season.

Karnataka's Health Minister Dinesh Gundu Rao on Monday advised senior citizens and those with comorbidities to wear masks, in light of rising COVID-19 cases in neighboring Kerala and other states. Speaking in Kodagu, Rao said there is no need to panic but the state will soon issue an advisory asking vulnerable groups to mask up. He directed government hospitals near border regions adjoining Kerala to remain alert, increase testing capacity and mandatorily test those with respiratory symptoms. This comes as India's active COVID caseload rose to 1,828 on Monday, with one death in Kerala where a new sub-variant was found.

India reported 335 new COVID-19 cases and 5 fatalities on Sunday, taking the total caseload to 4.5 crore and death toll to 5.33 lakh. Active cases rose to 1,701. A COVID sub-variant, JN.1, was detected in Kerala through genome sequencing of an elderly woman's sample from December 8th. She had mild symptoms and recovered. The variant was earlier found in Indian passengers at the Singapore airport months ago. Kerala Health Minister said JN.1 is not a cause for concern, though situation is being monitored. She asked people, especially those with comorbidities, to remain cautious but said the sub-variant has been identified and there is no need to worry.

The World Health Organization has warned countries to maintain strong COVID-19 surveillance and sequencing efforts due to a recent surge in respiratory illnesses globally. This increase is attributed to multiple pathogens including COVID-19, influenza, rhinovirus and others. WHO officials noted that the SARS-CoV-2 virus continues to evolve, with the JN.1 omicron subvariant already designated a Variant of Interest and showing increased circulation. WHO is continuing to assess the situation and has advised the public to follow health guidelines during the holiday season to protect themselves and others amid the viral resurgence. (Image Courtesy: @mvankerkhove on X)

The Centre officially confirms the presence of the JN.1 subvariant of Covid-19 in a patient from Kerala, marking India's first case. The variant is closely linked to the BA.2.86, known as Pirola, detected in the US and China. The patient from Thiruvananthapuram, who tested positive on December 8, has recovered. Kerala experiences a surge in Covid cases, with a majority being mild. A health ministry mock drill assesses preparedness, while experts suggest exploring the role of JN.1. The subvariant, first detected in the US, raises questions about its transmissibility and immune evasion.

Singapore experiences a spike in Covid-19 cases, reaching 56,043 in the week of December 3 to 9, compared to 32,035 the previous week. The Health Ministry reinstates mask advisories in crowded places and urges precautions for travelers. Average daily hospitalizations and ICU cases rise, prompting additional measures to safeguard healthcare capacity. The dominant strain, JN.1, raises concerns, but no clear evidence of increased transmissibility or severity. Singapore emphasizes vaccination's crucial role, urging public cooperation. Daily updates on Covid-19 cases will be available on the Health Ministry's website from December 19, 2023. 

The Union Ministry of Health has activated preparedness measures following the identification of the JN.1 subvariant of COVID in Kerala during routine surveillance by the Indian SARS-CoV-2 Genomics Consortium. Dr. Rajiv Bahl, Director-General of the Indian Council of Medical Research, confirmed the case, prompting a nationwide mock drill to assess public health readiness. While cases in Kerala remain mostly mild, health authorities stress the importance of ongoing vigilance. The JN.1 subvariant, initially detected in the United States in September 2023, exhibits upper respiratory symptoms. Medical experts advise vigilance without panic as the situation evolves.

Tamil Nadu gears up to tackle a potential COVID-19 outbreak following a spike in cases in neighboring Kerala and in Singapore. Health Minister Ma. Subramanian instructs officials to implement preventive measures, conduct RT-PCR tests for increased fever cases, and closely monitors the situation. Kerala reports a case of the JN.1 subvariant, emphasizing a growing trend in infections. Tamil Nadu maintains 36 active cases with a 98.94% discharge rate. Health authorities are in contact with Kerala counterparts, and a mock drill assesses public health preparedness. The Union Health Ministry coordinates efforts to monitor points of entry.

As Singapore witnesses a 75% spike in COVID-19 cases, the Ministry of Health strongly encourages mask-wearing in crowded places, irrespective of health status. The surge, with 56,043 cases from Dec 3 to 9, sees average daily hospitalizations rising from 225 to 350. The intensive care unit reports an increase from four to nine daily cases. Predominantly, the JN.1 variant is responsible. The Ministry emphasizes personal and social responsibility, urging unwell individuals to stay home and advising travelers to wear masks, obtain travel insurance, and avoid poorly ventilated crowded areas.

The detection of the JN.1 COVID subvariant in Kerala sparks worries, with a case found in a 79-year-old woman. Originating from the United States in September 2023, JN.1, a descendant of BA.2.86, raises concerns about its impact. The patient, with mild influenza-like symptoms, had recovered from COVID-19. While an Indian traveler also tested positive in Singapore, there's no surge in cases reported. Surveillance by INSACOG assures vigilance, with expert Rajeev Jayadevan noting JN.1's fast spread and immune evasion. China reports seven cases, emphasizing the need for caution amid rising COVID infections in India.